Burke Steven Keith
SEC insider (Form 3/4/5 filer). CIK 0001619834. Director at SCYNEXIS INC (SCYX) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in JERSEY CITY, NJ.
Companies Burke Steven Keith has filed insider reports for
- SCYNEXIS INC (SCYX): Director
- Akebia Therapeutics, Inc. (AKBA): Officer, SVP, Chief Medical Officer
Burke Steven Keith
CIK: 0001619834
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 18, 2026SCYX
SCYNEXIS INC
AwardDirect5.8K shares- - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect21.6K shares at avg. $1.39$30K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect20.7K shares at avg. $1.39$29K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect25.4K shares at avg. $1.39$35K - Jan 30, 2026AKBA
Akebia Therapeutics, Inc.
AwardDirect204K shares- - Mar 3, 2025AKBA
Akebia Therapeutics, Inc.
SaleDirect7.1K shares at avg. $1.83$13K - Feb 3, 2025AKBA
Akebia Therapeutics, Inc.
SaleDirect27.2K shares at avg. $2.10$57K - Feb 3, 2025AKBA
Akebia Therapeutics, Inc.
SaleDirect23.3K shares at avg. $2.10$49K - Jan 31, 2025AKBA
Akebia Therapeutics, Inc.
AwardDirect194.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2026 |  SCYX SCYNEXIS INC | Award | 5,750 | - | $0 | Direct |
| Feb 2, 2026 |  AKBA Akebia Therapeutics, Inc. | Sale | 21,582 | $1.39 | $29,999 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 20,701 | $1.39 | $28,774 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale | 25,375 | $1.39 | $35,271 | Direct |
| Jan 30, 2026 | AKBA Akebia Therapeutics, Inc. | Award | 204,000 | - | $0 | Direct |
| Mar 3, 2025 | AKBA Akebia Therapeutics, Inc. | Sale | 7,144 | $1.83 | $13,074 | Direct |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | Sale | 27,236 | $2.10 | $57,196 | Direct |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | Sale | 23,270 | $2.10 | $48,867 | Direct |
| Jan 31, 2025 | AKBA Akebia Therapeutics, Inc. | Award | 194,900 | - | - | Direct |
1-9 of 9 transactions